Skip to main content
. 2021 Jul 8;16(7):e0252132. doi: 10.1371/journal.pone.0252132

Fig 2. Expression of E-cadherin/CDH1 in primary CRC and liver metastases; correlation with MSI2 expression.

Fig 2

(A) Representative IHC expression of E-cadherin/CDH1 in primary CRC and liver metastasis from individual patient. (B) H-score for E-cadherin/CDH1 in primary tumor and liver metastasis (n = 28). (C) Correlation of H-score for MSI2 and E-cadherin/CDH1 in liver metastases (R2 = 0.505, p = 0.027).